These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 10372803)

  • 1. Requirement of multiple SH3 domains of Nck for ligand binding.
    Wunderlich L; Gohér A; Faragó A; Downward J; Buday L
    Cell Signal; 1999 Apr; 11(4):253-62. PubMed ID: 10372803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of Cbl phosphorylation by the Abl tyrosine kinase and the Nck SH2/SH3 adaptor.
    Miyoshi-Akiyama T; Aleman LM; Smith JM; Adler CE; Mayer BJ
    Oncogene; 2001 Jul; 20(30):4058-69. PubMed ID: 11494134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine phosphorylation of p120cbl in BCR/abl transformed hematopoietic cells mediates enhanced association with phosphatidylinositol 3-kinase.
    Jain SK; Langdon WY; Varticovski L
    Oncogene; 1997 May; 14(18):2217-28. PubMed ID: 9174058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of interactions of Nck with Sos and dynamin.
    Wunderlich L; Faragó A; Buday L
    Cell Signal; 1999 Jan; 11(1):25-9. PubMed ID: 10206341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Nck with tyrosine-phosphorylated SLP-76 in activated T lymphocytes.
    Wunderlich L; Faragó A; Downward J; Buday L
    Eur J Immunol; 1999 Apr; 29(4):1068-75. PubMed ID: 10229072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A casein kinase I activity is constitutively associated with Nck.
    Lussier G; Larose L
    J Biol Chem; 1997 Jan; 272(5):2688-94. PubMed ID: 9006905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fyn associates with Cbl and phosphorylates tyrosine 731 in Cbl, a binding site for phosphatidylinositol 3-kinase.
    Hunter S; Burton EA; Wu SC; Anderson SM
    J Biol Chem; 1999 Jan; 274(4):2097-106. PubMed ID: 9890970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yeast two-hybrid in vivo association of the Src kinase Lyn with the proto-oncogene product Cbl but not with the p85 subunit of PI 3-kinase.
    Dombrosky-Ferlan PM; Corey SJ
    Oncogene; 1997 May; 14(17):2019-24. PubMed ID: 9160881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abl family kinases and Cbl cooperate with the Nck adaptor to modulate Xenopus development.
    Adler CE; Miyoshi-Akiyama T; Aleman LM; Tanaka M; Smith JM; Mayer BJ
    J Biol Chem; 2000 Nov; 275(46):36472-8. PubMed ID: 10967110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential inhibition of signaling pathways by dominant-negative SH2/SH3 adapter proteins.
    Tanaka M; Gupta R; Mayer BJ
    Mol Cell Biol; 1995 Dec; 15(12):6829-37. PubMed ID: 8524249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Cbl-Nck and Nck-Pak1 interactions in myeloid FcgammaRII signaling.
    Izadi KD; Erdreich-Epstein A; Liu Y; Durden DL
    Exp Cell Res; 1998 Dec; 245(2):330-42. PubMed ID: 9851874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The SH2- and SH3-containing Nck protein transforms mammalian fibroblasts in the absence of elevated phosphotyrosine levels.
    Chou MM; Fajardo JE; Hanafusa H
    Mol Cell Biol; 1992 Dec; 12(12):5834-42. PubMed ID: 1280326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the Abl tyrosine kinase in vivo by Src homology 3 domains from the Src homology 2/Src homology 3 adaptor Nck.
    Smith JM; Katz S; Mayer BJ
    J Biol Chem; 1999 Sep; 274(39):27956-62. PubMed ID: 10488144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coexistence of phosphotyrosine-dependent and -independent interactions between Cbl and Bcr-Abl.
    Gaston I; Johnson KJ; Oda T; Bhat A; Reis M; Langdon W; Shen L; Deininger MW; Druker BJ
    Exp Hematol; 2004 Jan; 32(1):113-21. PubMed ID: 14725908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The product of the cbl oncogene forms stable complexes in vivo with endogenous Crk in a tyrosine phosphorylation-dependent manner.
    Ribon V; Hubbell S; Herrera R; Saltiel AR
    Mol Cell Biol; 1996 Jan; 16(1):45-52. PubMed ID: 8524328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The BCR/ABL oncogene alters interaction of the adapter proteins CRKL and CRK with cellular proteins.
    Uemura N; Salgia R; Li JL; Pisick E; Sattler M; Griffin JD
    Leukemia; 1997 Mar; 11(3):376-85. PubMed ID: 9067577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of CBL with BCR-ABL and CRKL in BCR-ABL-transformed myeloid cells.
    Bhat A; Kolibaba K; Oda T; Ohno-Jones S; Heaney C; Druker BJ
    J Biol Chem; 1997 Jun; 272(26):16170-5. PubMed ID: 9195915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of Cbl with two adapter proteins, Grb2 and Crk, upon T cell activation.
    Buday L; Khwaja A; Sipeki S; Faragó A; Downward J
    J Biol Chem; 1996 Mar; 271(11):6159-63. PubMed ID: 8626404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3' kinase pathway.
    Sattler M; Salgia R; Okuda K; Uemura N; Durstin MA; Pisick E; Xu G; Li JL; Prasad KV; Griffin JD
    Oncogene; 1996 Feb; 12(4):839-46. PubMed ID: 8632906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The signal transduction through Grb2/Ash in hematopoietic cells.
    Odai H; Hanazono Y; Sasaki K; Iwamatu A; Yazaki Y; Hirai H
    Leukemia; 1997 Apr; 11 Suppl 3():405-7. PubMed ID: 9209406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.